Home > Income Statement > CORONA REMEDIES

CORONA REMEDIES
Profit After Tax

    Back to Income Statement
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Profit After Tax History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Profit After Tax ₹149 Cr₹905 Cr₹85 Cr₹85 Cr

What is the latest Profit After Tax of CORONA REMEDIES ?

The latest Profit After Tax ratio of CORONA REMEDIES is ₹149 Cr based on Mar2026 Consolidated results.
Year Profit After Tax
Mar2026₹149 Cr
Mar2025₹905 Cr
Mar2024₹85 Cr
Mar2023₹85 Cr

How is Profit After Tax of CORONA REMEDIES Trending?

Years Profit After Tax % Change
Mar2026 ₹149 Cr
-83.49
Mar2025 ₹905 Cr
965.63
Mar2024 ₹85 Cr
0.00
Mar2023 ₹85 Cr -

Compare Profit After Tax of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹13,289.3 Cr 1% 3.7% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,202.0 Cr 0.5% -2.9% 5% Stock Analytics
DIVIS LABORATORIES ₹264,141.0 Cr 5% 7.2% 49.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹174,402.0 Cr -0.5% -4.5% 28.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,868.0 Cr 2.7% 8.4% 5.1% Stock Analytics
CIPLA ₹111,650.0 Cr 2.4% 2.4% -12.9% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

1%

3.7%

NA
SENSEX

2.8%

4.4%

-10.1%


You may also like the below Video Courses